{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:21:34Z","timestamp":1787239294438,"version":"build-2736575974"},"reference-count":40,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Generalitat Valenciana, Valencia, Spain","award":["CIAICO 2023\/013"],"award-info":[{"award-number":["CIAICO 2023\/013"]}]},{"name":"Generalitat Valenciana, Valencia, Spain","award":["CIAPOS 2023\/276"],"award-info":[{"award-number":["CIAPOS 2023\/276"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Acute myocardial infarction (AMI) is a critical medical condition that requires immediate attention to minimise heart damage and improve survival rates. Early identification and prompt treatment are essential to save the patient\u2019s life. Currently, the treatment strategy focuses on restoring blood flow to the myocardium as quickly as possible. However, reperfusion activates several cellular cascades that contribute to organ dysfunction, resulting in the ischaemia\/reperfusion (I\/R) injury. The search for treatments against AMI and I\/R injury is urgent due to the shortage of effective treatments at present. In this regard, histone deacetylase (HDAC) inhibitors emerge as a promising treatment against myocardial infarction. The objective of this systematic review is to analyse the effects of HDAC inhibitors on ventricular function, cardiac remodelling and infarct size, among other parameters, focusing on the signalling pathways that may mediate these cardiovascular effects and protect against AMI. Methods: Original experimental studies examining the effects of HDAC inhibitors on AMI were included in the review using the PubMed and Scopus databases. Non-experimental papers were excluded. The SYRCLE RoB tool was used to assess risk of bias and the results were summarised in a table and presented in sections according to the type of HDAC inhibitor used. Results: A total of 18 studies were included, 10 of them using trichostatin A (TSA) as an HDAC inhibitor and concluding that the treatment improved ventricular function, reduced infarct size, and inhibited myocardial hypertrophy and remodelling after AMI. Other HDAC inhibitors, such as suberoylanilide hydroxamic acid (SAHA), valproic acid (VPA), mocetinostat, givinostat, entinostat, apicidin, and RGFP966, were also analysed, showing antioxidant and anti-inflammatory effects, an improvement in cardiac function and remodelling, and a decrease in apoptosis, among other effects. Conclusions: HDAC inhibitors constitute a significant promise for the treatment of AMI due to their diverse cardioprotective effects. However, high risk of selection, performance, and detection bias in the in vivo studies means that their application in the clinical setting is still a long way off and more research is needed to better understand their benefits and possible side effects.<\/jats:p>","DOI":"10.3390\/jcm13247797","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T07:42:18Z","timestamp":1734680538000},"page":"7797","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Histone Deacetylase Inhibitors as a Promising Treatment Against Myocardial Infarction: A Systematic Review"],"prefix":"10.3390","volume":"13","author":[{"given":"Eduardo","family":"Sanchez-Fernandez","sequence":"first","affiliation":[{"name":"Department of Physiology, Universitat de Valencia, 46010 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3018-4683","authenticated-orcid":false,"given":"Sol","family":"Guerra-Ojeda","sequence":"additional","affiliation":[{"name":"Department of Physiology, Universitat de Valencia, 46010 Valencia, Spain"},{"name":"Instituto Investigaci\u00f3n Hospital Cl\u00ednico-INCLIVA, 46010 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0932-7870","authenticated-orcid":false,"given":"Andrea","family":"Suarez","sequence":"additional","affiliation":[{"name":"Department of Physiology, Universitat de Valencia, 46010 Valencia, Spain"},{"name":"Instituto Investigaci\u00f3n Hospital Cl\u00ednico-INCLIVA, 46010 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2968-3349","authenticated-orcid":false,"given":"Eva","family":"Serna","sequence":"additional","affiliation":[{"name":"Department of Physiology, Universitat de Valencia, 46010 Valencia, Spain"},{"name":"Instituto Investigaci\u00f3n Hospital Cl\u00ednico-INCLIVA, 46010 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7695-2898","authenticated-orcid":false,"given":"Maria D.","family":"Mauricio","sequence":"additional","affiliation":[{"name":"Department of Physiology, Universitat de Valencia, 46010 Valencia, Spain"},{"name":"Instituto Investigaci\u00f3n Hospital Cl\u00ednico-INCLIVA, 46010 Valencia, Spain"},{"name":"Center for Biomedical Research Network on Cardiovascular Diseases (CIBER-CV), 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Task Force for the Universal Definition of Myocardial Infarction Fourth Universal Definition of Myocardial Infarction (2018)","volume":"72","author":"Thygesen","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/B978-0-12-394309-5.00006-7","article-title":"Cell Biology of Ischemia\/Reperfusion Injury","volume":"298","author":"Kalogeris","year":"2012","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"H1723","DOI":"10.1152\/ajpheart.00553.2011","article-title":"Pathophysiology of Myocardial Reperfusion Injury: Preconditioning, Postconditioning, and Translational Aspects of Protective Measures","volume":"301","author":"Sanada","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMra071667","article-title":"Myocardial Reperfusion Injury","volume":"357","author":"Yellon","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e016349","DOI":"10.1161\/JAHA.120.016349","article-title":"Histone Deacetylase Inhibitors: A Novel Strategy for Neuroprotection and Cardioprotection Following Ischemia\/Reperfusion Injury","volume":"9","author":"Pickell","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/CIRCULATIONAHA.105.559724","article-title":"Inhibition of Histone Deacetylation Blocks Cardiac Hypertrophy Induced by Angiotensin II Infusion and Aortic Banding","volume":"113","author":"Kee","year":"2006","journal-title":"Circulation"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1161\/CIRCULATIONAHA.106.625467","article-title":"Suppression of Class I and II Histone Deacetylases Blunts Pressure-Overload Cardiac Hypertrophy","volume":"113","author":"Kong","year":"2006","journal-title":"Circulation"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Hooijmans, C.R., Rovers, M.M., de Vries, R.B.M., Leenaars, M., Ritskes-Hoitinga, M., and Langendam, M.W. (2014). SYRCLE\u2019s Risk of Bias Tool for Animal Studies. BMC Med. Res. Methodol., 14.","DOI":"10.1186\/1471-2288-14-43"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"De la Rosa Gonz\u00e1lez, A., Guerra-Ojeda, S., Camacho-Villa, M.A., Valls, A., Alegre, E., Quintero-Bernal, R., Martorell, P., Chenoll, E., Serna-Garc\u00eda, M., and Mauricio, M.D. (2024). Effect of Probiotics on Gastrointestinal Health Through the Aryl Hydrocarbon Receptor Pathway: A Systematic Review. Foods, 13.","DOI":"10.3390\/foods13213479"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Rajasingh, J., Thangavel, J., Siddiqui, M.R., Gomes, I., Gao, X., Kishore, R., and Malik, A.B. (2011). Improvement of Cardiac Function in Mouse Myocardial Infarction after Transplantation of Epigenetically-Modified Bone Marrow Progenitor Cells. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0022550"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1755-1536-7-10","article-title":"HDAC Class I Inhibitor, Mocetinostat, Reverses Cardiac Fibrosis in Heart Failure and Diminishes CD90+ Cardiac Myofibroblast Activation","volume":"7","author":"Zakharova","year":"2014","journal-title":"Fibrogenesis Tissue Repair"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1161\/CIRCULATIONAHA.113.002416","article-title":"Histone Deacetylase Inhibition Blunts Ischemia\/Reperfusion Injury by Inducing Cardiomyocyte Autophagy","volume":"129","author":"Xie","year":"2014","journal-title":"Circulation"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"44281","DOI":"10.18632\/oncotarget.17471","article-title":"The Optimization of Cell Therapy by Combinational Application with Apicidin-Treated Mesenchymal Stem Cells after Myocardial Infarction","volume":"8","author":"Cho","year":"2017","journal-title":"Oncotarget"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3892\/ijmm.2017.3101","article-title":"Trichostatin A Attenuates Oxidative Stress-Mediated Myocardial Injury through the FoxO3a Signaling Pathway","volume":"40","author":"Guo","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1159\/000493672","article-title":"Inhibition of Histone Deacetylases Prevents Cardiac Remodeling After Myocardial Infarction by Restoring Autophagosome Processing in Cardiac Fibroblasts","volume":"49","author":"Wang","year":"2018","journal-title":"Cell Physiol. Biochem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.yjmcc.2018.04.011","article-title":"HDAC Inhibition Helps Post-MI Healing by Modulating Macrophage Polarization","volume":"119","author":"Kimbrough","year":"2018","journal-title":"J. Mol. Cell Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ebiom.2018.12.003","article-title":"HDAC Inhibitor Valproic Acid Protects Heart Function through Foxm1 Pathway after Acute Myocardial Infarction","volume":"39","author":"Tian","year":"2018","journal-title":"EBioMedicine"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"H332","DOI":"10.1152\/ajpheart.00444.2019","article-title":"LncRNA TUG1 Mediates Ischemic Myocardial Injury by Targeting miR-132-3p\/HDAC3 Axis","volume":"318","author":"Su","year":"2020","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.7150\/thno.70821","article-title":"Diabetes Impairs Cardioprotective Function of Endothelial Progenitor Cell-Derived Extracellular Vesicles via H3K9Ac Inhibition","volume":"12","author":"Huang","year":"2022","journal-title":"Theranostics"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1096\/fj.08-108548","article-title":"Histone Deacetylase Inhibition Reduces Myocardial Ischemia-Reperfusion Injury in Mice","volume":"22","author":"Granger","year":"2008","journal-title":"FASEB J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.cardiores.2007.08.010","article-title":"Inhibition of Histone Deacetylases Triggers Pharmacologic Preconditioning Effects against Myocardial Ischemic Injury","volume":"76","author":"Zhao","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.arcmed.2012.04.007","article-title":"Trichostatin A Ameliorates Myocardial Ischemia\/Reperfusion Injury through Inhibition of Endoplasmic Reticulum Stress-Induced Apoptosis","volume":"43","author":"Yu","year":"2012","journal-title":"Arch. Med. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1124\/jpet.111.189910","article-title":"Inhibition of Histone Deacetylases Preserves Myocardial Performance and Prevents Cardiac Remodeling through Stimulation of Endogenous Angiomyogenesis","volume":"341","author":"Zhang","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Zhao, T.C., Du, J., Zhuang, S., Liu, P., and Zhang, L.X. (2013). HDAC Inhibition Elicits Myocardial Protective Effect through Modulation of MKK3\/Akt-1. PLoS ONE, 8.","DOI":"10.1371\/annotation\/29be7977-2e22-40cd-8a71-b3fbb99de9d5"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.yjmcc.2014.03.005","article-title":"Selective Inhibition of Class I but Not Class IIb Histone Deacetylases Exerts Cardiac Protection from Ischemia Reperfusion","volume":"72","author":"Aune","year":"2014","journal-title":"J. Mol. Cell Cardiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41419-017-0174-5","article-title":"Givinostat Reduces Adverse Cardiac Remodeling through Regulating Fibroblasts Activation","volume":"9","author":"Milan","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"176475","DOI":"10.1016\/j.ejphar.2024.176475","article-title":"Sodium Valproate Treatment Reverses Endothelial Dysfunction in Aorta from Rabbits with Acute Myocardial Infarction","volume":"970","author":"Suarez","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13195-020-00746-8","article-title":"Trichostatin A Ameliorates Alzheimer\u2019s Disease-Related Pathology and Cognitive Deficits by Increasing Albumin Expression and A\u03b2 Clearance in APP\/PS1 Mice","volume":"13","author":"Su","year":"2021","journal-title":"Alzheimers Res. Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000507937","article-title":"Trichostatin A Induces Autophagy in Cervical Cancer Cells by Regulating the PRMT5-STC1-TRPV6-JNK Pathway","volume":"106","author":"Liu","year":"2021","journal-title":"Pharmacology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/mutage\/geab018","article-title":"Trichostatin A Mitigates Radiation-Induced Teratogenesis in C57Bl\/6 Mice","volume":"36","author":"Haritwal","year":"2021","journal-title":"Mutagenesis"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1161\/hh2201.099452","article-title":"P38 Triggers Late Preconditioning Elicited by Anisomycin in Heart: Involvement of NF-kappaB and iNOS","volume":"89","author":"Zhao","year":"2001","journal-title":"Circ. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/med.10017","article-title":"Anti-Tumor Mechanisms of Valproate: A Novel Role for an Old Drug","volume":"22","author":"Blaheta","year":"2002","journal-title":"Med. Res. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3892\/ol.2024.14330","article-title":"Effect of Valproic Acid on Histone Deacetylase Expression in Oral Cancer (Review)","volume":"27","author":"Wang","year":"2024","journal-title":"Oncol. Lett."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"10742484221140303","DOI":"10.1177\/10742484221140303","article-title":"Association of Valproic Acid Use With Post-Myocardial Infarction Heart Failure Development: A Meta-Analysis of Two Retrospective Case-Control Studies","volume":"27","author":"English","year":"2022","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Kim, Y.S., Kim, M., Cho, D.I., Lim, S.Y., Jun, J.H., Kim, M.R., Kang, B.G., Eom, G.H., Kang, G., and Yoon, S. (2022). PSME4 Degrades Acetylated YAP1 in the Nucleus of Mesenchymal Stem Cells. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14081659"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4196\/kjpp.2023.27.4.407","article-title":"PSME4 Determines Mesenchymal Stem Cell Fate towards Cardiac Commitment through YAP1 Degradation","volume":"27","author":"Kim","year":"2023","journal-title":"Korean J. Physiol. Pharmacol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"5438","DOI":"10.2174\/1381612820666140205144900","article-title":"Teratogenic Activity of HDAC Inhibitors","volume":"20","author":"Giavini","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00204-020-02928-7","article-title":"Neurotoxic Effects in Zebrafish Embryos by Valproic Acid and Nine of Its Analogues: The Fish-Mouse Connection?","volume":"95","author":"Brotzmann","year":"2021","journal-title":"Arch. Toxicol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s13402-017-0314-z","article-title":"Histone Deacetylase Inhibitors VPA and TSA Induce Apoptosis and Autophagy in Pancreatic Cancer Cells","volume":"40","author":"Granato","year":"2017","journal-title":"Cell Oncol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/24\/7797\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:56:21Z","timestamp":1760115381000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/24\/7797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,20]]},"references-count":40,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["jcm13247797"],"URL":"https:\/\/doi.org\/10.3390\/jcm13247797","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,20]]}}}